Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 for the study record, indicating a metadata/version change in the COMBAT entry. This update does not modify the study content or eligibility details.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:26.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:39:38.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be an internal version update and does not modify study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-21T20:25:32.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-07T05:00:18.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T13:41:35.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1; no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T00:00:36.000Z thumbnail image

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.